News & Events
Crinetics Announces 2021 Plans at J.P. Morgan Healthcare Conference
Scott Struthers, Ph. D. , Founder & CEO of Crinetics, presented 2020 update and 2021 plans.
READ MOREPodcast: Work Continues on New Drugs/Therapies for Pituitary Patients
We wondered how this critically important work for pituitary patients was affected by the pandemic. Dr. Struthers gives us an “insider’s view” of their work and an update on the progress in the development of these new medications for acromegaly, neuroendocrine tumors, congenital hyperinsulinism, Cushing’s disease, congenital adrenal hyperplasia, and more.
READ MORECrinetics Pharmaceuticals to Participate in December Investor Conferences
Dr. Scott Struthers and Dr. Alan Krasner present at 32nd annual Piper Sandler Healthcare Conference December 1st-3rd, 2020 Webcast available until December 3rd.
READ MORECrinetics Pharmaceuticals Appoints Acromegaly Expert, Peter Trainer, Vice President of Clinical Endocrinology
“Dr. Trainer is a global leader in the endocrine community who has treated patients, published extensively and educated physicians on the identification and treatment of endocrine disease, particularly in the area of neuroendocrinology,” said Alan S. Krasner, M.
READ MORECrinetics Hosting Key Opinion Leader Meeting Focusing on Oral Paltusotine for Treatment of Acromegaly
Crinetics hosts a virtual Key Opinion Leader (KOL) meeting on oral paltusotine for the treatment of acromegaly on Friday, November 20, 2020 at 11:00 am Eastern Time. Peter Trainer, MD and Monica Roberto Gadelha, MD, PhD discuss implications of Phase 2 ACROBAT studies with oral paltusotine.
READ MOREThird Quarter 2020 Financial Results and Corporate Update
Positive topline results for Phase 2 trials of oral paltusotine (acromegaly), CRN04777 received Rare Pediatric Disease Designation (congenital hyperinsulinism)
READ MORETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
